V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004755 | 300003291 | 1.7 | 81.8 | Curative (C) | 2017-01-02 | 2017-01-14 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | N | 300025258 | CAPECITABINE + OXALIPLATIN |
| 300004756 | 300003291 | 1.51 | 67 | Palliative (P) | 2015-03-23 | 2015-03-25 | ESPAC-4 TRIAL | 02 | null | 300025258 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004757 | 300007497 | 1.87 | 73.2 | Neo-adjuvant (N) | 2013-10-09 | 2013-04-11 | CARBOPLATIN + RT | N | N | 300025290 | CARBOPLATIN + RT |
| 300004758 | 300003292 | null | 70 | Adjuvant (A) | 2015-06-03 | 2015-06-07 | FLUOROURACIL + OXALIPLATIN | 02 | N | 300025301 | PEMBROLIZUMAB |
| 300004759 | 300003292 | 1.6 | 67.4 | Palliative (P) | null | 2015-01-11 | Dasatinib | N | N | 300025301 | BCG |
| 300004760 | 300003292 | 1.63 | 69.8 | Palliative (P) | 2013-04-28 | 2013-04-28 | PEMBROLIZUMAB | 02 | N | 300025301 | IPILIMUMAB |
| 300004761 | 300003293 | 1.73 | 77.8 | Palliative (P) | 2016-09-07 | 2016-09-26 | CYTARABINE + DAUNORUBICIN | 02 | N | 300025309 | CISPLATIN + ETOPOSIDE |
| 300004762 | 300003294 | 1.8 | 69.8 | null | 2016-10-03 | 2016-10-03 | ABC-08 Trial | 02 | N | 300025311 | OXALIPLATIN + MDG |
| 300004763 | 300003294 | 1.65 | 68.4 | Adjuvant (A) | 2016-08-11 | 2016-08-18 | Carboplatin AUC 2 - 5 | 2 | N | 300025311 | BENDAMUSTINE + RITUXIMAB |
| 300004764 | 300007499 | 1.61 | 61 | Disease modification (D) | 2017-02-06 | 2017-02-18 | CNS Choriod Plexus SIOP 2009, CycEV | 02 | Y | 300025329 | PEMBROLIZUMAB |
| 300004765 | 300007994 | 1.76 | 88.9 | Neo-adjuvant (N) | 2014-06-15 | 2014-06-25 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 300025342 | CARBOPLATIN + CETUXIMAB + FU |
| 300004766 | 300007994 | 1.72 | 107.15 | Palliative (P) | 2015-11-13 | 2015-11-26 | Capecitabine + Cisplatin | null | N | 300025342 | GEMCARBO |
| 300004767 | 300003295 | 1.79 | 76.3 | Adjuvant (A) | 2013-09-04 | 2013-10-04 | ABC-08 Trial | N | N | 300025358 | GEMCITABINE + NAB-PACLITAXEL |
| 300004768 | 300003295 | 1.68 | 60.2 | Palliative (P) | null | 2015-01-08 | Oxaliplatin + Modified de Gramont | 2 | N | 300025358 | MAESTRO TRIAL |
| 300004770 | 300003297 | 1.56 | 70.2 | Palliative (P) | null | 2015-07-22 | Oxaliplatin + Modified de Gramont | N | N | 300025365 | CARBOPLATIN + ETOPOSIDE |
| 300004773 | 300007995 | 1.79 | null | Palliative (P) | 2015-04-19 | 2015-05-03 | Cisplatin + Etoposide (3 day) | N | N | 300025393 | FLUOROURACIL |
| 300004776 | 300003299 | 1.58 | null | Palliative (P) | 2015-08-08 | 2015-08-26 | Carbo F | N | N | 300025405 | OXALIPLATIN + MDG |
| 300004777 | 300006204 | 1.81 | 107.4 | Palliative (P) | 2014-12-25 | 2015-01-01 | CARBOPLATIN + RT | 1 | N | 300025406 | CARBO + FLUOROURACIL |
| 300004779 | 300003300 | 1.88 | 75.5 | Curative (C) | 2016-09-11 | 2016-09-27 | DARS Trial | 2 | Y | 300025421 | BEVACIZUMAB |
| 300004781 | 300003302 | 1.6 | 64.5 | Palliative (P) | 2014-01-24 | 2014-02-03 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | N | 300025445 | OXALIPLATIN + MDG |
| 300004782 | 300003302 | 1.72 | 71.8 | Curative (C) | 2014-11-25 | 2014-12-09 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 2 | Y | 300025445 | CARBOPLATIN |
| 300004783 | 300007502 | 1.65 | 61.4 | Adjuvant (A) | 2017-06-25 | 2017-07-11 | Hydroxycarbamide | 02 | N | 300025455 | CAPECITABINE + CARBOPLATIN |
| 300004784 | 300003303 | 1.68 | 95 | null | 2014-11-03 | 2014-11-03 | CARBOPLATIN + RT | 02 | null | 300025458 | NOT MATCHED |
| 300004785 | 300003303 | null | 74.3 | Palliative (P) | 2016-02-04 | 2016-02-04 | FLUOROURACIL | Y | N | 300025458 | IPILIMUMAB + NIVOLUMAB |
| 300004787 | 300003305 | 1.67 | 60.7 | Palliative (P) | 2017-07-07 | 2017-07-07 | Capecitabine + Cisplatin | 02 | null | 300025497 | CARBOPLATIN + ETOPOSIDE |
| 300004788 | 300003305 | 2.06 | 86 | Curative (C) | 2016-09-08 | 2016-10-05 | Capecitabine + Cisplatin | N | Y | 300025497 | CAPECITABINE + CISPLATIN |
| 300004789 | 300003305 | null | null | Adjuvant (A) | 2014-01-29 | 2014-02-15 | EC | N | N | 300025497 | TRASTUZUMAB |
| 300004790 | 300003306 | 1.86 | 80 | Palliative (P) | 2013-10-27 | 2013-11-07 | ECX | 02 | N | 300025514 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004794 | 300003308 | 1.56 | 74.5 | Disease modification (D) | 2017-08-25 | 2017-09-28 | FLUOROURACIL + MITOMYCIN | N | N | 300025539 | CISPLATIN + FLUOROURACIL + RT |
| 300004795 | 300003309 | 1.59 | 99.5 | Neo-adjuvant (N) | 2016-03-16 | 2016-03-16 | Ipilimumab | 02 | N | 300025542 | FLUOROURACIL |
| 300004796 | 300003309 | null | null | Curative (C) | 2015-01-25 | 2015-02-01 | CARBOPLATIN + RT | N | Y | 300025542 | CARBO + FLUOROURACIL |
| 300004797 | 300003310 | null | 63.7 | Curative (C) | 2017-03-11 | 2017-09-03 | Capecitabine + Oxaliplatin 21day | N | N | 300025561 | NOT MATCHED |
| 300004798 | 300003311 | 1.65 | null | Curative (C) | 2014-02-06 | 2014-03-06 | CISPLATIN + ETOPOSIDE | N | Y | 300025568 | TCF |
| 300004799 | 300006210 | 1.78 | 63.2 | Palliative (P) | 2014-05-14 | 2014-06-12 | CARBOPLATIN + RT | Y | N | 300025569 | CARBOPLATIN |
| 300004800 | 300006210 | null | 125.7 | Curative (C) | 2015-04-08 | 2015-04-13 | Cisplatin + Fluorouracil + RT 5day | N | N | 300025569 | PACLITAXEL |
| 300004801 | 300006210 | 1.82 | 57.4 | Adjuvant (A) | 2015-03-21 | 2015-03-26 | Bevacizumab 7.5mg/kg | N | N | 300025569 | CARBOPLATIN + ETOPOSIDE |
| 300004805 | 300003314 | 1.76 | 53.9 | Adjuvant (A) | 2014-03-17 | 2014-03-23 | Carboplatin AUC 6 - 10 | N | N | 300025607 | CAPECITABINE + GEMCITABINE |
| 300004806 | 300003315 | 1.87 | 86.4 | Palliative (P) | 2017-05-07 | 2017-05-11 | Gemcitabine + Capecitabine | 2 | N | 300025612 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004807 | 300003316 | 1.71 | 64.7 | Curative (C) | 2017-06-19 | 2017-06-29 | CARBOPLATIN | 02 | Y | 300025617 | GEMCITABINE + NAB-PACLITAXEL |
| 300004808 | 300003316 | null | 79 | Curative (C) | 2014-10-12 | 2014-11-04 | Carboplatin AUC 6 - 10 | 02 | Y | 300025617 | GEMCARBO |
| 300004810 | 300003317 | 1.58 | 56.7 | null | 2015-02-12 | 2015-03-03 | ESPAC-4 TRIAL | N | N | 300025642 | CARBOPLATIN |
| 300004811 | 300003318 | 1.6 | 48.6 | Palliative (P) | 2013-03-21 | 2013-03-26 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | null | 300025645 | HYDROXYCARBAMIDE |
| 300004812 | 300003318 | null | 137 | Palliative (P) | 2016-05-21 | 2016-06-20 | Capecitabine + Oxaliplatin 21day | N | N | 300025645 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004813 | 300003319 | 1.8 | 0 | Adjuvant (A) | 2013-07-12 | 2013-07-31 | Cisplatin + Fluorouracil + RT 5day | N | Y | 300025651 | PACLITAXEL |
| 300004814 | 300006214 | 1.61 | 59.7 | Palliative (P) | null | 2018-02-23 | Oxaliplatin + Modified de Gramont | Y | Y | 300025657 | CAPECITABINE + MITOMYCIN + RT |
| 300004815 | 300003320 | 1.61 | 65.4 | null | 2017-07-02 | 2017-07-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | 300025664 | CISPLATIN + ETOPOSIDE |
| 300004816 | 300003320 | null | 54.2 | Curative (C) | 2016-01-22 | 2016-01-23 | CARBOPLATIN + RT | Y | null | 300025664 | OXALIPLATIN + MDG |
| 300004817 | 300003321 | 1.7 | 88 | Curative (C) | 2014-08-21 | 2014-09-03 | CAPECITABINE + MITOMYCIN + RT | N | Y | 300025681 | ESPAC TRIAL |
| 300004818 | 300003321 | -1 | null | Palliative (P) | 2015-12-09 | 2015-12-28 | Mitotane 2g | N | N | 300025681 | CARBO + FLUOROURACIL |
| 300004819 | 300003322 | null | 75.3 | Disease modification (D) | 2017-02-20 | 2017-03-05 | FEC 60 or 75 | N | N | 300025704 | CISPLATIN + VINORELBINE |